Cognex Corporation $CGNX Shares Sold by Vontobel Holding Ltd.

Key Points

• Vontobel Holding reduced its Cognex stake by 53.1% in the third quarter, selling 35,942 shares and retaining 31,785 shares valued at approximately $1.93 million. Despite the sale, institutional investors own 88.12% of CGNX.
• Analyst sentiment remains positive overall, with a consensus “Moderate Buy” rating and an average price target of $75.57, although some firms maintain “Hold” ratings.
• Cognex reported quarterly EPS of $0.45, beating estimates of $0.42, while revenue increased 16.9% year over year to $291.26 million. The company also declared a quarterly dividend of $0.085 per share, representing a 0.6% yield.

Vontobel Holding Ltd. cut its stake in shares of Cognex Corporation (NASDAQ:CGNX - Free Report) by 53.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,785 shares of the scientific and technical instruments company's stock after selling 35,942 shares during the period. Vontobel Holding Ltd.'s holdings in Cognex were worth $1,928,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of CGNX. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Cognex in the 2nd quarter worth $26,000. Rakuten Securities Inc. bought a new position in shares of Cognex during the second quarter valued at about $32,000. Transamerica Financial Advisors LLC bought a new position in shares of Cognex during the second quarter valued at about $32,000. Mather Group LLC. lifted its position in shares of Cognex by 81.3% during the third quarter. Mather Group LLC. now owns 446 shares of the scientific and technical instruments company's stock valued at $27,000 after purchasing an additional 200 shares in the last quarter. Finally, Elevation Wealth Partners LLC boosted its holdings in Cognex by 635.4% during the second quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company's stock worth $35,000 after purchasing an additional 413 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have issued reports on CGNX shares. Zacks Research downgraded shares of Cognex from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, October 6th. Needham & Company LLC reissued a "buy" rating and set a $80.00 target price on shares of Cognex in a research report on Tuesday, September 15th. Truist Financial set a $74.00 target price on shares of Cognex and gave the stock a "hold" rating in a research report on Monday, October 5th. Weiss Ratings upgraded Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research note on Tuesday, August 11th. Finally, Cantor Fitzgerald upped their target price on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a report on Friday, August 7th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $75.57.

Cognex Stock Performance

Shares of CGNX stock opened at $53.99 on Monday. The stock has a market capitalization of $9.08 billion, a P/E ratio of 52.42 and a beta of 1.48. The firm's 50 day moving average is $61.08 and its 200 day moving average is $61.67. Cognex Corporation has a 12 month low of $34.60 and a 12 month high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts' consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The business had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same period in the previous year, the business earned $0.25 EPS. Cognex's revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities analysts predict that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Stockholders of record on Thursday, August 20th were issued a $0.0850 dividend. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend was Thursday, August 20th. Cognex's dividend payout ratio (DPR) is presently 33.01%.

Cognex Company Profile

Cognex Corporation NASDAQ: CGNX develops machine vision products and technologies that help businesses automate manufacturing, logistics and other industrial processes. Its systems enable machines to inspect, identify, measure and guide products, components and materials with limited human intervention.

The company's product portfolio includes industrial vision cameras, vision sensors, image-based barcode readers, three-dimensional vision systems and software for image processing and analysis.

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.